Skip to main content
# Title Department Research Year
11 Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies Department of Medicinal Chemistry 2024
12 Electrospun Tamarindus indica-loaded antimicrobial PMMA/cellulose acetate/PEO nanofibrous scaffolds for accelerated wound healing: In-vitro and in-vivo assessments Department of Pharmacognosy 2024
13 Spectrofluorimetric determination of Alogliptin benzoate through condensation with ninhydrin and phenylacetaldehyde: application to dosage form and rat plasma Department of Pharmaceutical Analytical Chemistry 2024
14 Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors. Department of Pharmaceutical Organic Chemistry 2024
15 Regiodivergent biosynthesis of bridged bicyclononanes Department of Pharmacognosy 2024
16 Zirconium-based hydrophobic-MOFs as innovative electrode modifiers for flibanserin determination: Exploring the electrooxidation mechanism using a comprehensive spectroelectrochemical study Department of Pharmaceutical Analytical Chemistry 2024
17 Thunbergiside A: An unprecedented neolignan isolated from Gardenia thunbergia L. f. and the antifungal activity of selected phytochemicals Department of Pharmacognosy 2024
18 Development of an innovative turn-on fluorescent probe for targeted in-vivo detection of nitric oxide in rat brain extracts as a biomarker for migraine disease Department of Pharmaceutical Analytical Chemistry 2024
19 Phenotypic detection of ESBL and MBL producing Klebsiella pneumoniae in critically ill patients with nosocomial pneumonia Department of Microbiology and Immunology 2024
20 Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation Department of Pharmaceutical Organic Chemistry 2023